Key facts
| Price (PPV) | 164.60 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amlodipinevalsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DB01 |
| Manufacturer | COOPER PHARMA |
| Presentation | Boite de 30 |
| Hospital price | 102.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension artérielle essentielle. L’association amlodipine-valsartan est indiquée chez les patients dont la tension artérielle est insuffisamment contrôlée par le valsartan seul ou par l'amlodipine seule. L’association amlodipine-valsartan est indiquée pour le traitement initial de l'hypertension artérielle. La décision de prescrire L’association amlodipine-valsartan en traitement initial de l'hypertension artérielle doit reposer sur une évaluation des bénéfices et des risques potentiels.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Suliat 5 mg / 160 mg (AFRIC-PHAR) contains the same active substance as Valmep 5 mg / 160 mg (Amlodipine | Valsartan) at the same strength, but in a different pack: Boite de 14 at 105.20 MAD, i.e. 7.51 MAD per unit against 5.49 MAD for Valmep 5 mg / 160 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Lotevan 5 mg / 160 mg | ZENITH PHARMA | Boite de 30 | 198.20 MAD | 6.61 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Suliat 5 mg / 160 mg | AFRIC-PHAR | Boite de 14 | 105.20 MAD | 7.51 / unit |
| Suliat 5 mg / 160 mg | AFRIC-PHAR | Boite de 28 | 185.20 MAD | 6.61 / unit |
| Xilam 5 mg / 160 mg | SOTHEMA | Boite de 28 | 185.20 MAD | 6.61 / unit |
| Exforge 5 mg / 160 mg | NOVARTIS PHARMA MAROC | Boîte de 28 | 224 MAD | 8 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Valmep 5 mg / 160 mg
Valmep 5 mg / 160 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by COOPER PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Valmep 5 mg / 160 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Valmep 5 mg / 160 mg
Answers to common questions from Moroccan patients about this drug.